Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,708,880
-
Share change
-
+978,794
-
Total reported value
-
$334,123,652
-
Put/Call ratio
-
364%
-
Price per share
-
$21.27
-
Number of holders
-
81
-
Value change
-
+$20,098,383
-
Number of buys
-
59
-
Number of sells
-
25
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2015
As of 30 Jun 2015,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,708,880 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, FMR LLC, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., and Citadel Advisors LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.